COMMONWEALTH BIOTECHNOLOGIES, INC. 8-K

Company

Inhibitor Therapeutics, Inc.

Filed

August 26, 1998

Period of Report

August 24, 1998

Accession Number

0000916641-98-000969

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →